CONSERV BIOSCIENCE
ConserV Bioscience is a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases.
CONSERV BIOSCIENCE
Industry:
Biotechnology Health Care
Founded:
2020-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.conservbio.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Similar Organizations
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
MediBiofarma
MediBioPharma is a clinical-stage biotechnology company which is fcused on drug discovery.
Current Employees Featured
Investors List
Department of Health and Social Care (DHSC)
Department of Health and Social Care (DHSC) investment in Grant - ConserV Bioscience
Official Site Inspections
http://www.conservbio.com Semrush global rank: 5.33 M Semrush visits lastest month: 1.56 K
- Host name: aragats-lon.cloudhosting.uk
- IP address: 185.199.220.84
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "ConserV Bioscience"
conservbio.com - Our mission is to develop safe and โฆ
Our mission is to develop safe and effective vaccines which offer broad protection against infections from viruses that mutate frequently. NewsSee details»
ConserV Bioscience - Crunchbase Company Profile
Headquarters Regions Europe, Middle East, and Africa (EMEA) Founded Date 2020 Operating Status Active Last Funding Type Grant Legal Name ConserV โฆSee details»
ConserV Bioscience - LinkedIn
ConserV Bioscience | 347 followers on LinkedIn. Generating Protective Immune Responses to Highly Mutable Viruses Twitter: @conservbiosci | ConserV is a late-stage vaccine development company ...See details»
ConserV Bioscience Company Profile | Management and
Find contact information for ConserV Bioscience. Learn about their Research & Development, Business Services market share, competitors, and ConserV Bioscience's email format.See details»
ConserV Bioscience - VentureRadar
ConserV Bioscience Limited, based in Oxfordshire, United Kingdom, is a clinical-stage vaccine development company focused on advancing safe and effective vaccines that protect against โฆSee details»
Conservbio 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for Conservbio. Use the PitchBook Platform to explore the full profile.See details»
ConserV Bioscience in collaboration with Walter Reed Army โฆ
LONDON, UNITED KINGDOM, January 16, 2024 / โ ConserV Bioscience Limited (โConserVโ), a clinical-stage biotechnology company focused on developing vaccines that protect against โฆSee details»
ConserV Bioscience - Company Profile & Staff Directory | ContactOut
ConserV is a late-stage vaccine development company focused on advancing safe and effective vaccines that protect against endemic and emergent infectious diseases. We have a pipeline โฆSee details»
ConserV Bioscience Overview | SignalHire Company Profile
ConserV Bioscience is a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases.See details»
ConserV Bioscience and eTheRNA immunotherapies to โฆ
ConserV Bioscience has a pipeline of eight vaccines at various stages of pre-clinical and clinical development including vaccine candidates to protect against broad-spectrum influenza (Phase โฆSee details»
ConserV - Drug pipelines, Patents, Clinical trials - Synapse
Explore ConserV with its drug pipeline, therapeutic area, technology platform, 1 news, Disease Domain:Infectious Diseases, Immune System Diseases, Technology Platform:Prophylactic โฆSee details»
ConserV Bioscience - Medtech Alert
Feb 24, 2022 ConserV is a late-stage vaccine development company focused on advancing safe and effective vaccines that protect against endemic and emergent infectious diseases. We โฆSee details»
ConserV Bioscience Ltd.. (1/19/21). "Press Release: ConserV โฆ
ConserV Bioscience Limited (โConserVโ), a clinical-stage biotechnology company focused on developing vaccines that protect against endemic and emergent infectious diseases and โฆSee details»
ConserV Bioscience works on mutation-proof coronavirus shots โฆ
Jan 20, 2025 UK biotech ConserV Bioscience has joined with Californiaโs Lawrence Livermore National Laboratory to develop broad-spectrum coronavirus vaccines as concerns mount over โฆSee details»
ConserV Bioscience and eTheRNA immunotherapies to โฆ
Mar 4, 2021 ConserV Bioscience has a pipeline of eight vaccines at various stages of pre-clinical and clinical development including vaccine candidates to protect against broad-spectrum โฆSee details»
ConserV Bioscience and Lawrence Livermore National Laboratory โฆ
Jan 19, 2021 London, United Kingdom and Livermore, California, January 19, 2021 โ ConserV Bioscience Limited (โConserVโ), a clinical-stage biotechnology company focused on โฆSee details»
ConserV Bioscience pan-coronavirus project has been awarded UK โฆ
Feb 24, 2022 ConserV Bioscience has a pipeline of eight vaccines at various stages of pre-clinical and clinical development including vaccine candidates to protect against broad โฆSee details»
ConserV Bioscience-ๅจ่็ฝ - vbdata.cn
ConserV Bioscience ๆฏไธๅฎถๅๆ็ซ่ๅผๅๅ ฌๅธ๏ผไธๆณจไบๅผๅๅฎๅ จๆๆ็็ซ่๏ผไปฅ้ข้ฒๅฐๆนๆงๅ็ชๅไผ ๆ็ ใSee details»
ConserV Bioscience pan-coronavirus project has been awarded UK โฆ
ConserV Bioscience pan-coronavirus project has been awarded UK Aid funding by the UK Vaccine Network, delivered by Innovate UK LONDON , Feb. 24, 2022 /PRNewswire/ โ โฆSee details»
ConserV Bioscience and Lawrence Livermore National Laboratory โฆ
Jan 19, 2021 This collaboration brings together ConserV's expertise in identifying antigens and Lawrence Livermore National Laboratory's nanolipoprotein particle technology ("NLP") delivery โฆSee details»